- IBDEI3IB ; ; 19-NOV-2015
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,1003,0)
- ;;=RELATIONAL PROBLEMS^23^99
- ;;^UTILITY(U,$J,358.4,1004,0)
- ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^25^99
- ;;^UTILITY(U,$J,358.4,1005,0)
- ;;=SEXUAL DYSFUNCTION^26^99
- ;;^UTILITY(U,$J,358.4,1006,0)
- ;;=SLEEP DISORDERS^27^99
- ;;^UTILITY(U,$J,358.4,1007,0)
- ;;=SUBSTANCE ABUSE-ALCOHOL^30^99
- ;;^UTILITY(U,$J,358.4,1008,0)
- ;;=SUBSTANCE ABUSE-AMPHETAMINE^31^99
- ;;^UTILITY(U,$J,358.4,1009,0)
- ;;=SUBSTANCE ABUSE-CANNABIS^32^99
- ;;^UTILITY(U,$J,358.4,1010,0)
- ;;=SUBSTANCE ABUSE-HALLUCINOGEN^34^99
- ;;^UTILITY(U,$J,358.4,1011,0)
- ;;=SUBSTANCE ABUSE-OPIOID^36^99
- ;;^UTILITY(U,$J,358.4,1012,0)
- ;;=SUBSTANCE ABUSE-PSYCHOACTIVE DRUGS^37^99
- ;;^UTILITY(U,$J,358.4,1013,0)
- ;;=SUBSTANCE ABUSE-SEDATIVE/HYPNOTIC^38^99
- ;;^UTILITY(U,$J,358.4,1014,0)
- ;;=SUBSTANCE ABUSE-TOBACCO^39^99
- ;;^UTILITY(U,$J,358.4,1015,0)
- ;;=SUBSTANCE ABUSE-COCAINE^33^99
- ;;^UTILITY(U,$J,358.4,1016,0)
- ;;=TRAUMA/STRESSOR-RELATED DISORDERS^40^99
- ;;^UTILITY(U,$J,358.4,1017,0)
- ;;=SUBSTANCE ABUSE-INHALANT^35^99
- ;;^UTILITY(U,$J,358.4,1018,0)
- ;;=INTELLECTUAL DISABILITIES^15^99
- ;;^UTILITY(U,$J,358.4,1019,0)
- ;;=RESEARCH^24^99
- ;;^UTILITY(U,$J,358.4,1020,0)
- ;;=SOMATOFORM DISORDERS^29^99
- ;;^UTILITY(U,$J,358.4,1021,0)
- ;;=ORTHOTIC DEVICES^3^100
- ;;^UTILITY(U,$J,358.4,1022,0)
- ;;=THERAPY EVALUATIONS^5^100
- ;;^UTILITY(U,$J,358.4,1023,0)
- ;;=HOME THERAPY SERVICES^1^100
- ;;^UTILITY(U,$J,358.4,1024,0)
- ;;=KT HOME HEALTH SERVICES^2^100
- ;;^UTILITY(U,$J,358.4,1025,0)
- ;;=SPEECH/LANG HOME HEALTH SERVICE^4^100
- ;;^UTILITY(U,$J,358.4,1026,0)
- ;;=AMPUTATION STATUS^1^101
- ;;^UTILITY(U,$J,358.4,1027,0)
- ;;=BRAIN DISORDERS^2^101
- ;;^UTILITY(U,$J,358.4,1028,0)
- ;;=CARDIOPULMONARY^4^101
- ;;^UTILITY(U,$J,358.4,1029,0)
- ;;=COMPLICATIONS DUE TO^5^101
- ;;^UTILITY(U,$J,358.4,1030,0)
- ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^11^101
- ;;^UTILITY(U,$J,358.4,1031,0)
- ;;=Z CODES^16^101
- ;;^UTILITY(U,$J,358.4,1032,0)
- ;;=BRAIN INJURY - TRAUMATIC^3^101
- ;;^UTILITY(U,$J,358.4,1033,0)
- ;;=FEMUR/THIGH/KNEE FRACTURE^6^101
- ;;^UTILITY(U,$J,358.4,1034,0)
- ;;=FOOT/TOE/ANKLE FRANCTURE^7^101
- ;;^UTILITY(U,$J,358.4,1035,0)
- ;;=HAND/FINGER FRACTURE^8^101
- ;;^UTILITY(U,$J,358.4,1036,0)
- ;;=HIP/PELVIS FRACTURE^9^101
- ;;^UTILITY(U,$J,358.4,1037,0)
- ;;=HUMERUS/SHOULDER FRACTURE^10^101
- ;;^UTILITY(U,$J,358.4,1038,0)
- ;;=TIBIA/FIBULA FRACTURE^14^101
- ;;^UTILITY(U,$J,358.4,1039,0)
- ;;=SPINE FRACTURE^13^101
- ;;^UTILITY(U,$J,358.4,1040,0)
- ;;=WRIST/FOREARM FRACTURE^15^101
- ;;^UTILITY(U,$J,358.4,1041,0)
- ;;=OTHER FRACTURE^12^101
- ;;^UTILITY(U,$J,358.4,1042,0)
- ;;=SPECIAL SERVICES^7^102
- ;;^UTILITY(U,$J,358.4,1043,0)
- ;;=TREATMENT^8^102
- ;;^UTILITY(U,$J,358.4,1044,0)
- ;;=MISCELLANEOUS^5^102
- ;;^UTILITY(U,$J,358.4,1045,0)
- ;;=IMMUNIZATIONS^3^102
- ;;^UTILITY(U,$J,358.4,1046,0)
- ;;=CHEMO ADMINISTRATION^1^102
- ;;^UTILITY(U,$J,358.4,1047,0)
- ;;=CHEMO DRUGS^2^102
- ;;^UTILITY(U,$J,358.4,1048,0)
- ;;=OTHER DRUGS^6^102
- ;;^UTILITY(U,$J,358.4,1049,0)
- ;;=MGMT L/T ANTICOAG TX^4^102
- ;;^UTILITY(U,$J,358.4,1050,0)
- ;;=NEW PATIENT^2^103
- ;;^UTILITY(U,$J,358.4,1051,0)
- ;;=ESTABLISHED PATIENT^1^103
- ;;^UTILITY(U,$J,358.4,1052,0)
- ;;=CONSULTATIONS^3^103
- ;;^UTILITY(U,$J,358.4,1053,0)
- ;;=POST OP^4^103
- ;;^UTILITY(U,$J,358.4,1054,0)
- ;;=ANEMIA^1^104
- ;;^UTILITY(U,$J,358.4,1055,0)
- ;;=BREAST & GYN NEOPLASMS^2^104
- ;;^UTILITY(U,$J,358.4,1056,0)
- ;;=COAGULATION DISORDERS^3^104
- ;;^UTILITY(U,$J,358.4,1057,0)
- ;;=COUNSELING & SCREENING^4^104
- ;;^UTILITY(U,$J,358.4,1058,0)
- ;;=GENITOURINARY NEOPLASMS^5^104
- ;;^UTILITY(U,$J,358.4,1059,0)
- ;;=GI CANCER^6^104
- ;;^UTILITY(U,$J,358.4,1060,0)
- ;;=HEAD/NECK/LUNG CANCER^7^104
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3IB 3962 printed Jan 18, 2025@03:50:31 Page 2
- IBDEI3IB ; ; 19-NOV-2015
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,1003,0)
- +2 ;;=RELATIONAL PROBLEMS^23^99
- +3 ;;^UTILITY(U,$J,358.4,1004,0)
- +4 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^25^99
- +5 ;;^UTILITY(U,$J,358.4,1005,0)
- +6 ;;=SEXUAL DYSFUNCTION^26^99
- +7 ;;^UTILITY(U,$J,358.4,1006,0)
- +8 ;;=SLEEP DISORDERS^27^99
- +9 ;;^UTILITY(U,$J,358.4,1007,0)
- +10 ;;=SUBSTANCE ABUSE-ALCOHOL^30^99
- +11 ;;^UTILITY(U,$J,358.4,1008,0)
- +12 ;;=SUBSTANCE ABUSE-AMPHETAMINE^31^99
- +13 ;;^UTILITY(U,$J,358.4,1009,0)
- +14 ;;=SUBSTANCE ABUSE-CANNABIS^32^99
- +15 ;;^UTILITY(U,$J,358.4,1010,0)
- +16 ;;=SUBSTANCE ABUSE-HALLUCINOGEN^34^99
- +17 ;;^UTILITY(U,$J,358.4,1011,0)
- +18 ;;=SUBSTANCE ABUSE-OPIOID^36^99
- +19 ;;^UTILITY(U,$J,358.4,1012,0)
- +20 ;;=SUBSTANCE ABUSE-PSYCHOACTIVE DRUGS^37^99
- +21 ;;^UTILITY(U,$J,358.4,1013,0)
- +22 ;;=SUBSTANCE ABUSE-SEDATIVE/HYPNOTIC^38^99
- +23 ;;^UTILITY(U,$J,358.4,1014,0)
- +24 ;;=SUBSTANCE ABUSE-TOBACCO^39^99
- +25 ;;^UTILITY(U,$J,358.4,1015,0)
- +26 ;;=SUBSTANCE ABUSE-COCAINE^33^99
- +27 ;;^UTILITY(U,$J,358.4,1016,0)
- +28 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^40^99
- +29 ;;^UTILITY(U,$J,358.4,1017,0)
- +30 ;;=SUBSTANCE ABUSE-INHALANT^35^99
- +31 ;;^UTILITY(U,$J,358.4,1018,0)
- +32 ;;=INTELLECTUAL DISABILITIES^15^99
- +33 ;;^UTILITY(U,$J,358.4,1019,0)
- +34 ;;=RESEARCH^24^99
- +35 ;;^UTILITY(U,$J,358.4,1020,0)
- +36 ;;=SOMATOFORM DISORDERS^29^99
- +37 ;;^UTILITY(U,$J,358.4,1021,0)
- +38 ;;=ORTHOTIC DEVICES^3^100
- +39 ;;^UTILITY(U,$J,358.4,1022,0)
- +40 ;;=THERAPY EVALUATIONS^5^100
- +41 ;;^UTILITY(U,$J,358.4,1023,0)
- +42 ;;=HOME THERAPY SERVICES^1^100
- +43 ;;^UTILITY(U,$J,358.4,1024,0)
- +44 ;;=KT HOME HEALTH SERVICES^2^100
- +45 ;;^UTILITY(U,$J,358.4,1025,0)
- +46 ;;=SPEECH/LANG HOME HEALTH SERVICE^4^100
- +47 ;;^UTILITY(U,$J,358.4,1026,0)
- +48 ;;=AMPUTATION STATUS^1^101
- +49 ;;^UTILITY(U,$J,358.4,1027,0)
- +50 ;;=BRAIN DISORDERS^2^101
- +51 ;;^UTILITY(U,$J,358.4,1028,0)
- +52 ;;=CARDIOPULMONARY^4^101
- +53 ;;^UTILITY(U,$J,358.4,1029,0)
- +54 ;;=COMPLICATIONS DUE TO^5^101
- +55 ;;^UTILITY(U,$J,358.4,1030,0)
- +56 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^11^101
- +57 ;;^UTILITY(U,$J,358.4,1031,0)
- +58 ;;=Z CODES^16^101
- +59 ;;^UTILITY(U,$J,358.4,1032,0)
- +60 ;;=BRAIN INJURY - TRAUMATIC^3^101
- +61 ;;^UTILITY(U,$J,358.4,1033,0)
- +62 ;;=FEMUR/THIGH/KNEE FRACTURE^6^101
- +63 ;;^UTILITY(U,$J,358.4,1034,0)
- +64 ;;=FOOT/TOE/ANKLE FRANCTURE^7^101
- +65 ;;^UTILITY(U,$J,358.4,1035,0)
- +66 ;;=HAND/FINGER FRACTURE^8^101
- +67 ;;^UTILITY(U,$J,358.4,1036,0)
- +68 ;;=HIP/PELVIS FRACTURE^9^101
- +69 ;;^UTILITY(U,$J,358.4,1037,0)
- +70 ;;=HUMERUS/SHOULDER FRACTURE^10^101
- +71 ;;^UTILITY(U,$J,358.4,1038,0)
- +72 ;;=TIBIA/FIBULA FRACTURE^14^101
- +73 ;;^UTILITY(U,$J,358.4,1039,0)
- +74 ;;=SPINE FRACTURE^13^101
- +75 ;;^UTILITY(U,$J,358.4,1040,0)
- +76 ;;=WRIST/FOREARM FRACTURE^15^101
- +77 ;;^UTILITY(U,$J,358.4,1041,0)
- +78 ;;=OTHER FRACTURE^12^101
- +79 ;;^UTILITY(U,$J,358.4,1042,0)
- +80 ;;=SPECIAL SERVICES^7^102
- +81 ;;^UTILITY(U,$J,358.4,1043,0)
- +82 ;;=TREATMENT^8^102
- +83 ;;^UTILITY(U,$J,358.4,1044,0)
- +84 ;;=MISCELLANEOUS^5^102
- +85 ;;^UTILITY(U,$J,358.4,1045,0)
- +86 ;;=IMMUNIZATIONS^3^102
- +87 ;;^UTILITY(U,$J,358.4,1046,0)
- +88 ;;=CHEMO ADMINISTRATION^1^102
- +89 ;;^UTILITY(U,$J,358.4,1047,0)
- +90 ;;=CHEMO DRUGS^2^102
- +91 ;;^UTILITY(U,$J,358.4,1048,0)
- +92 ;;=OTHER DRUGS^6^102
- +93 ;;^UTILITY(U,$J,358.4,1049,0)
- +94 ;;=MGMT L/T ANTICOAG TX^4^102
- +95 ;;^UTILITY(U,$J,358.4,1050,0)
- +96 ;;=NEW PATIENT^2^103
- +97 ;;^UTILITY(U,$J,358.4,1051,0)
- +98 ;;=ESTABLISHED PATIENT^1^103
- +99 ;;^UTILITY(U,$J,358.4,1052,0)
- +100 ;;=CONSULTATIONS^3^103
- +101 ;;^UTILITY(U,$J,358.4,1053,0)
- +102 ;;=POST OP^4^103
- +103 ;;^UTILITY(U,$J,358.4,1054,0)
- +104 ;;=ANEMIA^1^104
- +105 ;;^UTILITY(U,$J,358.4,1055,0)
- +106 ;;=BREAST & GYN NEOPLASMS^2^104
- +107 ;;^UTILITY(U,$J,358.4,1056,0)
- +108 ;;=COAGULATION DISORDERS^3^104
- +109 ;;^UTILITY(U,$J,358.4,1057,0)
- +110 ;;=COUNSELING & SCREENING^4^104
- +111 ;;^UTILITY(U,$J,358.4,1058,0)
- +112 ;;=GENITOURINARY NEOPLASMS^5^104
- +113 ;;^UTILITY(U,$J,358.4,1059,0)
- +114 ;;=GI CANCER^6^104
- +115 ;;^UTILITY(U,$J,358.4,1060,0)
- +116 ;;=HEAD/NECK/LUNG CANCER^7^104